Видео с ютуба Obesity Drug Stocks

Structure CEO Ray Stevens talks its obesity drug portfolio

People are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared Holz

Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold

Следующий этап гонки лекарств от ожирения

Altimmune CEO on what’s next for its experimental obesity drug

GLP-1 weight-loss drugs: Analyst discusses what investors should know

Eli Lilly's obesity drug will be a tailwind for the stock, says BMO's Evan Seigerman

Global market for anti-obesity drugs could reach $100B by 2030: Goldman Sachs

Weight loss drugs and stocks: Breaking down the GLP1 market for investors

Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline

Amgen shares fall on anti-obesity drug | REUTERS

Sectors UpClose: Obesity drug makers are riding a 'growth trend'

Novo Nordisk cuts some supply of Wegovy obesity drug as demand grows

Sectors UpClose: Obesity drugs ‘just in the first innings’ | REUTERS

Roche targets oral obesity drugs with Carmot takeover

Roche Obesity Pill Study: What Are the Side Effects of the Weight-Loss Drug?

Novo Nordisk Raises Forecasts on New Obesity Drug

How weight loss drugs could impact stocks

Mizuho's Jared Holz talks Viking Therapeutics' massive stock drop on obesity pill data

Lilly Ups Guidance as Novo, Pfizer Face Off in Obesity-Drug Tussle